s6y
Company name or ticker
Search
Neumora Therapeutics, Inc.
3
AMGEN INC: Initial statement of beneficial ownership of securities
Filed
Thursday, September 14, 2023
Period
Sep 14, 2023
Accession number
0000899243-23-019071
Documents
FORM 3 SUBMISSION
3
On sec.gov
Filing index
All files
Complete submission text
SGML header